SCHEMBL31401064

SCHEMBL31401064

CCOC(=O)C1CCCN(c2cccnc2)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.61
GAA P10253 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.54
CYP2C19 P33261 3/20 0.53
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2C9 P11712 2/20 0.53
MAPT P10636 1/20 0.53
KMT2A Q03164 2/20 0.53
HPGD P15428 2/20 0.53
MAPK1 P28482 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
MEN1 O00255 1/20 0.52
KDM4E B2RXH2 4/20 0.51
TDP1 Q9NUW8 2/20 0.51
LMNA P02545 1/20 0.51
HSD17B10 Q99714 3/20 0.50
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30637174 1.00 ALDH1A1 (0.61) ALDH1A1GAASMN1; SMN2CYP2C19CYP1A2
SCHEMBL31401389 1.00 ALDH1A1 (0.61) ALDH1A1GAASMN1; SMN2CYP2C19CYP1A2
SCHEMBL31516231 0.93 GAA (0.62) ALDH1A1GAASMN1; SMN2CYP2C19CYP1A2
SCHEMBL4684573 0.86 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2CYP2C19MAPTKMT2A
SCHEMBL30462011 0.86 GAA (0.67) ALDH1A1GAACYP2C19MAPTKMT2A
SCHEMBL2548994 0.86 GAA (0.67) ALDH1A1GAACYP2C19MAPTKMT2A
SCHEMBL31175186 0.86 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2CYP2C19KMT2AHPGD
SCHEMBL30637198 0.83 ALDH1A1 (0.56) ALDH1A1GAASMN1; SMN2CYP2C19CYP1A2
SCHEMBL24873099 0.82 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2CYP2C19CYP1A2CYP3A4
SCHEMBL30637176 0.81 HSD17B10 (0.53) ALDH1A1GAASMN1; SMN2CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP disclosed
WO-2025008058-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 WO disclosed